Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01246206 · MORE INFO

Limitations, agreements, and source contact

Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT · Source last updated 2018-06-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
The small number of patients makes the data hard to interpret.
point Of Contact
email
zalkadh@emory.edu
organization
Barbara Ann Karmanos Cancer Institute
phone
800-527-6266
title
Dr. Zaid Al-Kadhimi
Complete source fields
certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
The small number of patients makes the data hard to interpret.
point Of Contact
email
zalkadh@emory.edu
organization
Barbara Ann Karmanos Cancer Institute
phone
800-527-6266
title
Dr. Zaid Al-Kadhimi

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice